Retrieve available abstracts of 7 articles: HTML format
Single Articles
April 2025
MO X, Meng K, Xu B, Li Z, et al Nat10-mediated N4-acetylcytidine modification enhances Nfatc1 translation to
exacerbate osteoclastogenesis in postmenopausal osteoporosis.
Proc Natl Acad Sci U S A. 2025;122:e2423991122. PubMedAbstract available
March 2025
ZHANG W, Li W, Du J, Yang C, et al Dnmt3a-mediated hypermethylation of FoxO3 promotes redox imbalance during
osteoclastogenesis.
Proc Natl Acad Sci U S A. 2025;122:e2418023122. PubMedAbstract available
January 2025
LI S, Sun W, Li S, Zhu L, et al Tamsulosin ameliorates bone loss by inhibiting the release of Cl(-) through
wedging into an allosteric site of TMEM16A.
Proc Natl Acad Sci U S A. 2025;122:e2407493121. PubMedAbstract available
December 2024
LANZOLLA G, Sabini E, Beigel K, Khan MP, et al Pharmacological inhibition of HIF2 protects against bone loss in an experimental
model of estrogen deficiency.
Proc Natl Acad Sci U S A. 2024;121:e2416004121. PubMedAbstract available
November 2024
DU Y, Chen H, Zhou L, Guo Q, et al REGgamma is essential to maintain bone homeostasis by degrading TRAF6, preventing
osteoporosis.
Proc Natl Acad Sci U S A. 2024;121:e2405265121. PubMedAbstract available
April 2024
Correction for Keum et al., Heterogeneous osteoimmune profiles via single-cell
transcriptomics in osteoporotic patients who fail bisphosphonate treatment.
Proc Natl Acad Sci U S A. 2024;121:e2404416121. PubMed
February 2024
KEUM BR, Kim HJ, Lee J, Lee M, et al Heterogeneous osteoimmune profiles via single-cell transcriptomics in
osteoporotic patients who fail bisphosphonate treatment.
Proc Natl Acad Sci U S A. 2024;121:e2316871121. PubMedAbstract available